Trastuzumab MMAE
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), EGFR, Microtubule Associated
Related Pathways
Cytoskeletal Signaling, Angiogenesis, Antibody-drug Conjugate/ADC Related, JAK/STAT signaling, Tyrosine Kinase/Adaptors
Bioactivity
Trastuzumab MMAE is an antibody-drug conjugate (ADC) that combines a HER2-targeted antibody with Monomethyl auristatin E (MMAE), utilized in breast cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog